Skinvisible SKVI
OTC SKVI
$0.20 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Skinvisible (SKVI) Accounts Payables (2010 - 2026)

Skinvisible's (SKVI) quarterly Accounts Payables came in at $1.4 million in Q2 2026, up 29.93% year-over-year from $1.1 million in Q2 2025, and up 3.68% quarter-over-quarter from $1.4 million in Q1 2026.

Analysis

Skinvisible (SKVI) Accounts Payables (2010 - 2026) Analysis & Trends

Skinvisible has disclosed Accounts Payables across 17 years of filings, most recently posting $1.4 million for Q2 2026.

  • In Q2 2026, Accounts Payables rose 29.93% year-over-year to $1.4 million; the TTM figure through Jun 2026 stood at $1.4 million (up 29.93% YoY), while the FY2025 annual figure was $1.3 million, up 45.95% from the prior year.
  • Accounts Payables came in at $1.4 million for Q2 2026 at Skinvisible, up from $1.4 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $1.4 million in Q2 2026 to a low of $126057.0 in Q1 2023.
  • Average Accounts Payables over 5 years is $878660.9, with a median of $991985.5 recorded in 2022.
  • Year-over-year, Accounts Payables plunged 86.66% in 2023 and surged 322.74% in 2024.
  • Over 5 years, Accounts Payables stood at $1.2 million in 2022, then tumbled by 63.5% to $438668.0 in 2023, then soared by 95.82% to $858993.0 in 2024, then surged by 45.95% to $1.3 million in 2025, then grew by 12.05% to $1.4 million in 2026.
  • Per Business Quant data, the three most recent Accounts Payables figures were $1.4 million in Q2 2026, $1.4 million in Q1 2026, and $1.3 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 646.03 Bn 625.27 Bn 17.26 Bn 9.22 Bn
2 AbbVie 441.56 Bn 434.99 Bn 12.70 Bn 33.30 Bn
3 Merck 364.45 Bn 357.31 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 267.46 Bn 259.77 Bn 11.24 Bn 4.26 Bn
5 Pfizer 158.77 Bn 147.08 Bn 10.94 Bn 4.58 Bn
6 Sanofi 52.48 Bn 45.10 Bn 10.79 Bn 8.31 Bn
7 Revolution Medicines 44.15 Bn 44.15 Bn - 88.42 Mn
8 Incyte 25.31 Bn 20.77 Bn 1.57 Bn 250.40 Mn
9 United Therapeutics 21.29 Bn 18.63 Bn 683.80 Mn 497.80 Mn
10 Skinvisible 1.08 Mn 1.08 Mn 5,000.00 1.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.40 Mn
Mar 31, 2026 1.35 Mn
Dec 31, 2025 1.25 Mn
Sep 30, 2025 1.16 Mn
Jun 30, 2025 1.08 Mn
Mar 31, 2025 959,324.00
Dec 31, 2024 858,993.00
Sep 30, 2024 1.15 Mn
Jun 30, 2024 659,692.00
Mar 31, 2024 532,888.00
Dec 31, 2023 438,668.00
Sep 30, 2023 328,320.00
Jun 30, 2023 228,468.00
Mar 31, 2023 126,057.00
Dec 31, 2022 1.20 Mn
Sep 30, 2022 1.11 Mn
Jun 30, 2022 1.02 Mn
Mar 31, 2022 944,629.00
Dec 31, 2021 1.04 Mn
Sep 30, 2021 1.03 Mn